Company · CIK 1604477
SQZ Biotechnologies Co
| CIK | 1604477 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-12-10 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-260980 | 2021-11-12 | 2023-12-01 | 3 | |
| 333-252889 | 2021-02-09 | 2021-02-12 | 3 | |
| 333-249422 | 2020-10-09 | 2020-10-30 | 4 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-12-01 | EFFECTDeclared effective | 333-260980 | 9999999995-23-003512 |
| 2021-11-18 | EFFECTDeclared effective | 333-260980 | 9999999995-21-004408 |
| 2021-11-12 | S-3Shelf registered | 333-260980 | 0001193125-21-326292 |
| 2021-02-12 | 424B4Final prospectus | 333-252889 | 0001193125-21-041850 |
| 2021-02-11 | EFFECTDeclared effective | 333-252889 | 9999999995-21-000623 |
| 2021-02-09 | S-1Registration filed | 333-252889 | 0001193125-21-034349 |
| 2021-02-01 | DRSDraft made public | 377-04140 | 0000950123-21-000774 |
| 2020-10-30 | 424B4Final prospectus | 333-249422 | 0001193125-20-282707 |
| 2020-10-29 | EFFECTDeclared effective | 333-249422 | 9999999995-20-003031 |
| 2020-10-26 | S-1/AAmendment | 333-249422 | 0001193125-20-276011 |
| 2020-10-09 | S-1Registration filed | 333-249422 | 0001193125-20-267294 |
| 2020-07-21 | DRSDraft made public | 377-03317 | 0000950123-20-007066 |